Literature DB >> 29112421

Monometallic and Bimetallic Platinum Complexes with Fluorinated β-Diketiminate Ligands.

Ku Sun Choung1, Mohammad Din Islam1, Richard W Guo1, Thomas S Teets1.   

Abstract

Presented here are complexes of two different fluorinated β-diketiminate (NacNac) ligands with cyclometalated platinum. Reaction of the cyclometalated platinum dimers [Pt(C^N)(μ-X)]2 [C^N = 2-phenylpyridine (ppy), 2-(2,4-difluorophenyl)pyridine (F2ppy); X = Cl, Br] with lithium salts of backbone-fluorinated β-diketiminate ligands produces two structure types, depending on the temperature of the reaction. At milder temperatures (<80 °C), the major product is an unusual halide-bridged diplatinum complex, demonstrating a unique NacNac binding mode bridging the two platinum centers. At higher temperatures (>100 °C), the major species is a monoplatinum complex of the type Pt(C^N)(NacNac). The complexes display reduction waves in their cyclic voltammograms at mild potentials, as well as intense visible absorption bands (λ > 500 nm), that depend minimally on the identity of the C^N ligand or, in the case of the bimetallic complexes, the identity of the bridging halide. In addition, the monoplatinum complexes exhibit structured luminescence in the red and near-infrared regions deriving a NacNac-centered triplet state. All of these observations suggest that the NacNac π system contributes substantially to the frontier orbitals and motivates continued exploration of fluorinated β-diketiminate ligands in the design of complexes with desirable ligand-based redox and optical properties.

Entities:  

Year:  2017        PMID: 29112421     DOI: 10.1021/acs.inorgchem.7b02438

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  1 in total

1.  Metal free oxidation of vinamidine derivatives: a simple synthesis of α-keto-β-diimine ligands.

Authors:  Monika Tripathi; Vianney Regnier; Zakaria Ziani; Marc Devillard; Christian Philouze; David Martin
Journal:  RSC Adv       Date:  2018-11-14       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.